AnteoBind Order Received and Life Sciences Update
Filed with ASX · · 3 pages · English
Earlier from AnteoTech
- Strategic Review Outcomes
- Appointment of Interim CEO
- Half Year Results and Operational Update Presentation
- Results of Entitlement Offer
- Life Sciences Update
Later from AnteoTech
- Key Technical Milestone Achieved for Ultranode
- Agreement for combined Anteo X product in the USA
- $2.59 million R&D Tax Incentive received
- Queensland Government Grant Funding Update
- Appointment of MD & CEO and Annual Staff Review Process
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech